PCI president Montu Patel loses Gujarat state pharmacy council membership

Ahmedabad: The Health and Family Welfare Department has removed Montu Kumar Patel from the Gujarat State Pharmacy Council, raising questions about his continuation as president of the Pharmacy Council of India (PCI). The action follows a July 23 order from the administration of Daman & Diu and Dadra & Nagar Haveli, which cancelled Patel’s nomination and removed him from the council.

According to Medical Dialogues reports, the notification issued by the department serves as the first step in the process to remove Patel from his position as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. The department’s action formally initiates administrative proceedings that may affect his current role at the national council.

Patel, elected PCI president in 2022, was also serving as the president of the Gujarat State Pharmacy Council. In July, he came under investigation by the Central Bureau of Investigation (CBI) after raids were conducted at his residence in Ahmedabad.

The CBI probe concerns allegations that Patel granted approvals to pharmacy colleges in exchange for bribes, manipulated inspection procedures, and issued irregular recognitions to institutions.

Documents and financial records were seized during the raids, and the investigation has been expanded to other states. Medical Dialogues reported that these developments have increased scrutiny of PCI’s operations.

SC notes procedural lapses by PCI

The removal of Patel follows earlier criticism of PCI. In May, the Supreme Court had noted that the council rejected pharmacy college approvals without following due process and directed adherence to prescribed guidelines.

The developments coincide with ongoing discussions on reforms in pharmacy education regulation, including approval procedures, inspections, and recognition issuance.

According to DeshGujarat, the Health and Family Welfare Department has formally started the procedure to remove Patel as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. These administrative and legal steps indicate that PCI leadership may change as investigations and review of council processes continue.

Related Posts

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses